Ocular Therapeutix (OCUL) Amortizatization of Intangibles (2015 - 2017)
Ocular Therapeutix's (OCUL) quarterly Amortizatization of Intangibles came in at $6000.0 in Q2 2017, down 87.76% year-on-year from $49000.0 in Q2 2016, and down 45.45% quarter-over-quarter from $11000.0 in Q1 2017.
Ocular Therapeutix (OCUL) Amortizatization of Intangibles (2015 - 2017) Analysis & Trends
Ocular Therapeutix's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $6000.0 for Q2 2017.
- On a quarterly basis, Amortizatization of Intangibles fell 87.76% year-over-year to $6000.0 in Q2 2017; TTM through Dec 2017 was $17000.0, a 90.86% decrease from a year earlier, with the FY2017 full-year figure at $17000.0, down 90.86% from the prior year.
- Amortizatization of Intangibles retreated to $6000.0 in Q2 2017 per OCUL's latest filing, from $11000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $148000.0 in Q3 2015 and bottomed at $6000.0 in Q2 2017.
- The 3-year median for Amortizatization of Intangibles is $20500.0 (2015), against an average of $48600.0.
- Across the five-year window, Amortizatization of Intangibles soared 477.78% in 2016 and plunged 89.42% in 2017, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $96000.0 in 2015, then sank by 86.46% to $13000.0 in 2016, then slumped by 53.85% to $6000.0 in 2017.
- Per Business Quant, the three latest OCUL Amortizatization of Intangibles figures stand at $6000.0 (Q2 2017), $11000.0 (Q1 2017), and $13000.0 (Q4 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Ocular Therapeutix | 1.94 Bn | 1.94 Bn | 9.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Mar 31, 2017 | 11,000.00 |
| Dec 31, 2016 | 13,000.00 |
| Dec 31, 2016 | 13,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Sep 30, 2016 | 20,000.00 |
| Jun 30, 2016 | 49,000.00 |
| Jun 30, 2016 | 49,000.00 |
| Mar 31, 2016 | 104,000.00 |
| Mar 31, 2016 | 104,000.00 |
| Dec 31, 2015 | 96,000.00 |
| Dec 31, 2015 | 96,000.00 |
| Sep 30, 2015 | 148,000.00 |
| Sep 30, 2015 | 148,000.00 |
| Jun 30, 2015 | 21,000.00 |
| Jun 30, 2015 | 21,000.00 |
| Mar 31, 2015 | 18,000.00 |
| Mar 31, 2015 | 18,000.00 |